Q4 Revenue and Software Growth
Q4 total revenue of $41.2M, up 11% year over year; Q4 software revenue of $35.1M, up 14% year over year — the third consecutive quarter of accelerating revenue growth (excluding a one-time contingent deal).
Full-Year Revenue and Software Momentum
Fiscal 2025 total revenue of $157.0M, up 8% year over year; full-year software revenue of $134.0M, up 12% year over year, demonstrating multi-year acceleration in software growth (3% in 2023 → 7% in 2024 → 12% in 2025).
Improving Profitability Trends (Adjusted EBITDA and Net Loss)
Q4 adjusted EBITDA was negative $2.2M (‑5% margin) vs. a ‑12% margin in prior-year Q4; fiscal 2025 adjusted EBITDA was negative $10.2M (‑7%) vs. ‑13% in 2024. Net loss for fiscal 2025 was $10.7M (‑7% of revenue), improved from $17.2M (‑12%) in 2024; net loss per share improved to $0.17 from $0.29.
Strong Gross Margin and Efficiency Gains
Q4 gross margin was 77% and fiscal 2025 gross margin was 76% (up from 75% in 2024). Sales & marketing declined as a percent of revenue (35% FY 2025 vs 39% FY 2024), driven by lower personnel and marketing spend.
Large-Account Concentration and Retention
330 customers generated >$100K LTM, contributing $119M (76% of total revenue); 20 customers produced >$1M in revenue. Software dollar-based net retention exceeded 103% (total DBNR finished at 98%).
Generative AI and Auto Review Adoption Accelerating
Significant acceleration in adoption of generative AI capabilities (management cited a 4,100% increase attributable to these features) and strong first-year sales and repeat usage of Auto Review; management reported multi-terabyte matters revenue growth of over 30% year over year in Q4 and record total terabytes on platform.
Product & Commercial Improvements (Pricing & Packaging)
Company announced unified offering with Cecilia AI included per matter, a shift to per-gigabyte pricing tied to data growth, and simplified contracting alternatives — changes tested with customers and expected to improve win rates, reduce discounting, and lift long-term revenue and gross margin.
Healthy Balance Sheet
Ended Q4 with $114.6M in cash, cash equivalents, and short-term investments and no debt, providing runway to fund growth and product investments.
Forward Guidance Indicates Growth Trajectory
FY 2026 revenue guidance of $167M–$177M and software guidance of $145.5M–$152.5M, with management targeting adjusted EBITDA improvement toward breakeven by 2026.